Identify the genetic basis of myopathies
Subgroup Leader : Valérie BIANCALANA
We study rare and severe neuromuscular disorders caused by mutations in proteins controlling intracellular organization and dynamics. We aim to tackle the three main bottlenecks in this field:
.jpg)
Identify the genetic basis of myopathies, myalgia and high athletic performances
Project leaders : Valérie BIANCALANA, Johann BOHM, Jocelyn LAPORTE
Understand and cure myotubular/centronuclear myopathies through gene modulation and pharmacology
Project leader : Jocelyn LAPORTE
Understand and cure tubular aggregates myopathy and Stormorken syndrome through gene modulation and pharmacology
Project leader : Johann BOHM
Subgroup Leader : Valérie BIANCALANA
Subgroup Leader : Jocelyn LAPORTE
Article in a journal
Journal of Neuromuscular Diseases ; Volume: 6 ; Page: 289 - 305
Article in a journal
Acta Neuropathologica Communications ; Volume: 7 ; Page: 138
Article in a journal
Médecine/Sciences ; Volume: 35 ; Page: 43-44
Article in a journal
Acta Neuropathologica ; Volume: 137 ; Page: 501-519
Article in a journal
Human Molecular Genetics ; Volume: 28 ; Page: 1579-1593
Article in a journal
Journal of Neuropathology and Experimental Neurology ; Volume: 77 ; Page: 1101-1114
Article in a journal
Nature Communications ; Volume: 9
Article in a journal
Acta Neuropathologica Communications ; Volume: 6
Article in a journal
Nature Cell Biology ; Volume: 20 ; Page: 198-210
Article in a journal
Cell Calcium ; Volume: 76 ; Page: 1-9
Current fundings:

Her work, supervised by Dr. Jocelyn Laporte, is entitled "New Therapeutic Approaches for Neuromuscular Diseases."
Read more
Follow our publications and latest research on Researchgate : www.researchgate.net/profile/Jocelyn-Laporte
Raw data for our study on Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies. Mol Ther. 2021 Apr 30:S1525-0016(21)00247-1.
www.ncbi.nlm.nih.gov/geo/query/acc.cgi
www.sciencedirect.com/science/article/abs/pii/S1525001621002471
In the press: